Drug intelligence / Profile preview

terconazole + fluconazole

Development stage
Unknown
Lead developer
Janssen Pharmaceutica
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Topical, Vaginal, Oral, Intravenous
01

Overview

Terconazole + fluconazole is a combination of two antifungal agents, each with distinct but complementary mechanisms of action. Terconazole is an imidazole derivative used topically (usually as a vaginal cream or suppository) to treat fungal and yeast infections, particularly vulvovaginal candidiasis. It works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby stopping the growth of fungi[8][9]. Fluconazole is a triazole antifungal administered orally or intravenously for systemic and mucosal fungal infections including vaginal candidiasis. It also inhibits ergosterol synthesis in fungi by targeting the cytochrome P450 enzyme 14α-demethylase[6][7]. The combination may be considered in cases where both local and systemic treatment are desired for severe or recurrent vulvovaginal candidiasis; however, there are no widely marketed products combining these two agents into a single formulation. Both drugs are well-established treatments individually for Candida infections.

02

Targets

CYP51A1 (Sterol 14α-demethylase)

Beyond the preview

Go deeper on terconazole + fluconazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on terconazole + fluconazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call